Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

HeartSciences (HSCS) EPS (Weighted Average and Diluted) (2021 - 2025)

Historic EPS (Weighted Average and Diluted) for HeartSciences (HSCS) over the last 5 years, with Q4 2025 value amounting to -$0.85.

  • HeartSciences' EPS (Weighted Average and Diluted) rose 6255.51% to -$0.85 in Q4 2025 from the same period last year, while for Oct 2025 it was -$6.88, marking a year-over-year increase of 1190.78%. This contributed to the annual value of -$9.44 for FY2025, which is 4964.99% up from last year.
  • According to the latest figures from Q4 2025, HeartSciences' EPS (Weighted Average and Diluted) is -$0.85, which was up 6255.51% from -$1.58 recorded in Q3 2025.
  • HeartSciences' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.11 during Q2 2024, with a 5-year trough of -$79.36 in Q2 2023.
  • For the 5-year period, HeartSciences' EPS (Weighted Average and Diluted) averaged around -$6.98, with its median value being -$1.22 (2025).
  • Per our database at Business Quant, HeartSciences' EPS (Weighted Average and Diluted) tumbled by 1290983.61% in 2023 and then surged by 10013.86% in 2024.
  • HeartSciences' EPS (Weighted Average and Diluted) (Quarter) stood at -$0.31 in 2021, then grew by 29.03% to -$0.22 in 2022, then tumbled by 7136.36% to -$15.92 in 2023, then skyrocketed by 85.74% to -$2.27 in 2024, then skyrocketed by 62.56% to -$0.85 in 2025.
  • Its last three reported values are -$0.85 in Q4 2025, -$1.58 for Q3 2025, and -$2.24 during Q2 2025.